MENU
CORT
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Corcept Therapeutics (CORT) Earnings Date & Reports

Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic and neuropsychiatric disorders by modulating the effect of the hormone cortisol... Show more

A.I. Advisor
published Earnings

CORT is expected to report earnings to rise 112.94% to 34 cents per share on February 18

Corcept Therapeutics CORT Stock Earnings Reports
Q4'25
Est.
$0.34
Q3'25
Beat
by $0.03
Q2'25
Beat
by $0.10
Q1'25
Beat
by $0.02
Q4'24
Missed
by $0.12
The last earnings report on November 04 showed earnings per share of 15 cents, beating the estimate of 12 cents. With 460.71K shares outstanding, the current market capitalization sits at 7.96B.
View a ticker or compare two or three
CORT
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. CORT showed earnings on November 04, 2025. You can read more about the earnings report here.
A.I. Advisor
published General Information

General Information

a maker of drugs for the treatment of severe psychiatric and neurological diseases

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Pharmaceuticals Other
Address
149 Commonwealth Drive
Phone
+1 650 327-3270
Employees
352
Web
https://www.corcept.com